| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.ortinlabsindia.com | |
| Market Cap | 15.89 Cr. | |
| Enterprise Value(EV) | 21.57 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -5.01 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 42.15 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 8.57 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.28 | Calculated using Price: 19.54 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.81 Cr. | 8,131,392 Shares |
| FaceValue | 10 | |
| About Ortin Laboratories Ltd. | ||
| Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees. | ||
| 1 Day |
|
+2.61% |
| 1 Week |
|
-0.41% |
| 1 Month |
|
+1.24% |
| 3 Month |
|
-9.78% |
| 6 Month |
|
+9.35% |
| 1 Year |
|
+0.41% |
| 2 Year |
|
-24.28% |
| 5 Year |
|
+51.15% |
| 10 Year |
|
+63.75% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 4.04 | 3.65 | 2.16 | 2.86 | 5.21 | -2.31 | 5.38 | -3.57 | -0.86 | |
| Return on Capital Employed (%) | 11.55 | 11.01 | 9.58 | 10.14 | 11.76 | 8.93 | 3.27 | 1.56 | 1.66 | |
| Return on Assets (%) | 1.28 | 1.25 | 0.79 | 1 | 1.43 | -0.51 | 1.37 | -1.9 | -0.45 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 22 | 23 | 23 | 24 | 25 | 24 | 11 | 11 | 11 | 10 | |
| Non Curr. Liab. | 8 | 16 | 8 | 8 | 8 | 9 | 2 | 2 | 3 | 3 | |
| Curr. Liab. | 37 | 27 | 31 | 42 | 72 | 84 | 8 | 8 | 7 | 6 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 68 | 66 | 62 | 74 | 105 | 117 | 21 | 21 | 21 | 18 | |
| Non Curr. Assets | 24 | 35 | 23 | 21 | 23 | 24 | 15 | 15 | 15 | 15 | |
| Curr. Assets | 44 | 31 | 38 | 52 | 82 | 92 | 6 | 6 | 7 | 4 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 68 | 66 | 62 | 74 | 105 | 117 | 21 | 21 | 21 | 18 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 60 | 63 | 67 | 80 | 168 | 197 | 8 | 8 | 6 | 3 | |
| Other Income | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 61 | 64 | 67 | 80 | 168 | 198 | 8 | 8 | 6 | 3 | |
| Total Expenditure | -54 | -57 | -61 | -74 | -162 | -192 | -7 | -8 | -6 | -7 | |
| PBIDT | 7 | 6 | 6 | 6 | 7 | 6 | 1 | 1 | 1 | -3 | |
| Interest | -4 | -3 | -3 | -3 | -3 | -3 | -1 | -1 | 0 | -1 | |
| Depreciation | -2 | -2 | -2 | -2 | -2 | -2 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | -1 | -1 | -1 | -1 | 1 | 0 | 0 | 0 | ||
| Exceptional Items | 0 | ||||||||||
| PAT | 1 | 1 | 1 | 1 | 1 | -1 | 1 | 0 | 0 | -4 | |
| Adjusted EPS | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | -5 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | -1 | 1 | 2 | 2 | 7 | 3 | 18 | 2 | 0 | |
| Cash Fr. Inv. | 0 | 0 | -1 | -1 | -1 | -3 | -3 | 0 | 0 | 0 | |
| Cash Fr. Finan. | 1 | 2 | 0 | -1 | 0 | -3 | -1 | -10 | 0 | 1 | |
| Net Change | -1 | 1 | 0 | 0 | 1 | 0 | -1 | 8 | 2 | 1 | |
| Cash & Cash Eqvt | 1 | 2 | 2 | -14 | -13 | -13 | -14 | -5 | -4 | -3 |
|
Sat, 20 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Date: 20/04/2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Wed, 17 Apr 2024
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 For The FY Ending 31.03.2024 Disclosure under regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements ) Regulations 2015 for the FY ending 31.03.2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Wed, 17 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg.74 (5) of SEBI (DP) Regulations 2018 for the Quarter and year ended 31.03.2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Fri, 03 May 2024 |
High Delivery Percentage
|
Making Lower Lows for 3 days
|
Making Lower Lows for 2 Days
|
High Decrease in 3 Months
|
MFI Trending Down
|
